{"symbol": "NOVN", "name": "Novan", "next_earnings_utc": 1591783200, "next_earnings_period_start_date_utc": 1585612800, "next_earnings_period_end_date_utc": 1593475200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q2", "next_earnings_year": 2020, "next_earnings_quarter": 2, "next_earnings_revenue_num_analysts": null, "next_earnings_revenue_consensus": 950000.0, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": -0.07, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "novan.com", "year_founded": 2006, "street_address": "4105 Hopson Road", "city": "Morrisville", "state": "NC", "zipcode": "27560", "country": "United States", "phone_number": "919 485 8080", "short_description": "Novan, Inc., a clinical development-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases.", "long_description": "Novan, Inc., a clinical development-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology product candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, a topical anti-viral product candidate. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was founded in 2006 and is headquartered in Morrisville, North Carolina.", "industry_name": "Pharmaceuticals", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 30414969, "total_enterprise": 39743969, "number_of_employees": 42, "outstanding_shares": 75471388, "eps": -1.04043, "diluted_eps": -1.04043, "earnings_from_cont_operations": -30171000, "gross_profit": -5285000, "cash": 21785000, "total_debt": 31114000, "total_revenue": 5009000, "cash_from_operations": -25204000, "net_income": -30171000, "ebitda": -28652000, "year_low_stock_price": 0.215, "year_high_stock_price": 3.72, "seekingalpha_follower_count": 2364, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/NOVN.png"}